There is no doubt that the future of cell and gene therapies is bright. Biopharma manufacturers need to stay ahead of the curve by adapting to market trends and anticipating common challenges that might pop up along the way.
Whether it’s an equipment upgrade or implementing a flexible facility design, there are critical processes and adjustments to consider to get your facility ready for operations and keep it running smoothly.
By striking the right balance of technology, personnel, and partnerships, manufacturers can overcome current limitations and the pains that come with scaling up to establish and maintain GMP and capitalize on the CGT market’s growth.
Get Your 10-Point CQV Checklist to Ensure GMP
We’ve put together a comprehensive checklist to help you anticipate and overcome the common CQV challenges facing greenfield and brownfield CGT facility projects in the current market.
